Autres langues Jagsonpal Pharmaceuticals Limited

Actions

JAGSNPHARM

INE048B01027

Marché Fermé - NSE India S.E. Autres places de cotation 13:43:47 26/04/2024			Varia. 5j.	Varia. 1 janv.
343,6 ^INR	+3,06%		+7,97%	-11,66%

08/03	Jagsonpal Pharmaceuticals Limited lance Queezy-ER®.	CI
02/02	Jagsonpal Pharmaceuticals Limited annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Jagsonpal Pharmaceuticals Limited Launches Queezy-ER®	08/03
Jagsonpal Pharmaceuticals Limited Announces Chief Financial Officer Changes	02/02
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	03/11
Jagsonpal Pharmaceuticals' Net Profit Soars in Fiscal Q1	03/08/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02/08/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23/05/23
Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23/05/23
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others completed the acquisition of 43.73% stake in Jagsonpal Pharmaceuticals Limited from Aresko Progressive Private Limited and Rajpal Singh Kochhar.	31/03/23
Jagsonpal Pharmaceuticals Limited Announces Appointment of Abhishek Joshi as Company Secretary and Compliance Officer	13/02/23
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23
Jagsonpal Pharmaceuticals Limited Announces Executive Changes	31/12/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09/11/22
Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme	30/08/22
Jagsonpal Pharmaceuticals : Reply to Clarification Sought	16/08/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	09/08/22
Jagsonpal Pharmaceuticals : Appointment	16/07/22
Jagsonpal Pharmaceuticals Limited Announces Executive Changes	16/07/22
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm cancelled the acquisition of 26% stake in Jagsonpal Pharmaceuticals Limited.	20/06/22
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Jagsonpal Pharmaceuticals Limited

Actions

JAGSNPHARM

INE048B01027

Autres langues

Filtres